FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:

By |2014-12-05T15:36:09+00:00December 5th, 2014|Pharma News|

The biotech index is more than a triple bagger ramp since 2010. As a student of the market for over 20 years, with clinical research funding dropping, is there a top anywhere in sight? SZIMM Exclusive Interview with David Nierengarten, Ph.D., an Analyst at Wedbush Securities Covering the Biotechnology and Biopharmaceuticals Sector TWST: What's the FDA [...]

Read More
Comments Off on FDA Acceptance of Smaller Clinical Trials Offers Upside to Biotech Stocks:

Health Experts: Say No to Randomized Trials Testing Ebola Drugs

By |2017-04-25T18:03:53+00:00November 24th, 2014|Pharma News|

Karla Burke Life Sciences Senior Marketing Specialist at Thomson ReutersTop Contributor Leading health experts said that having decided it is ethical to use non-approved products to help deal with the Ebola virus epidemic, it would be unethical if those drugs were administered in the context of randomized clinical trials. “No one insisted Western medical workers [...]

Read More
Comments Off on Health Experts: Say No to Randomized Trials Testing Ebola Drugs
Go to Top